Skip to main content
Market intelligence
FENCHealthcare

Fennec Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 1, 2026Rosty RaykovDirectorSale9,747$9.62$93,766
May 11, 2026Chris A RallisDirectorSale8,346$7.04$58,756
May 1, 2026Rosty RaykovDirectorSale10,781$6.47$69,753